article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part i)

pharmaphorum

The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. The keynote address of the event entire came from Stella Kyriakides, commissioner for health and food safety at the European Commission. Her opener?

article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

About the author Sherene Min, MD, MPH, is Vice President of Global Clinical Development at ViiV Healthcare , a role she assumed in October 2019. With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety. References 1. World Health Organization.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Preparing for stricter standards on substances of human origin

European Pharmaceutical Review

Covered SoHO activities are “action[s], or series of actions, that [have] a direct impact on safety, quality or efficacy of SoHOs.” This will enable better monitoring of the safety and quality of these products, but it may also require additional investments in IT infrastructure.

Safety 65
article thumbnail

Biosimilars Market Set for Biggest Year Yet in 2023

PM360

The entirety of healthcare stakeholders is watching the biosimilars market closely because LOE events, particularly the Humira LOE, is likely to impact payers, providers, patients, and pharmaceutical manufacturers—both brand and biosimilar—and potentially society as a whole given the current controversy over rising drug prices.

article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

Active immunotherapy through vaccination has a far lower cost than mAb-based therapies, representing an important decrease of economic burden for healthcare systems at a global scale. 7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile.

article thumbnail

A Primer on Telepharmacy

Nixon Gwilt Law

Some of the country’s largest healthcare companies (e.g., CVS, Walgreens, and Optum) are using telepharmacy as part of their long-term strategy to deliver whole-person healthcare. Due to the success of the North Dakota Telepharmacy Project, the Board of Pharmacy in North Dakota permanently implemented telepharmacy regulations in 2003.

Medical 52
article thumbnail

How To Write Your Medical Sales Resume With Cathy Lanzalaco

Evolve Your Success

This was in late 2003. My very forward-thinking boss at that time said, “We could say that you probably know a little bit more about benefits than most people because a lot of them have to do with the healthcare piece. I do a lot of work with healthcare professionals and medical salespeople. Go save us some money.”